The human immunodeficiency virus type 1 Nef protein was expressed in Escherichia coil as a C-terminal fusion with glutathione S-transferase (GST). The ability of GST-Nefto act as a substrate for cellular kinases in vitro was examined by incubation of purified GST-Nef fusion proteins, immobilized on glutathione-agarose beads, with cytoplasmic extracts from a number of human cell lines. In the presence of [y32P]ATP, phosphorylation of Nef occurred predominantly on serine residues. Studies with protein kinase inhibitors suggested that protein kinase C (PKC) was involved in Nef phosphorylation. This was supported further by the demonstration that purified PKC was also able to phosphorylate Nef in the absence of cell extract. Serine/threonine phosphorylation of Nef was also observed in v&o when Nef was expressed with a C-terminal GST or 6-histidine tag in Spodopterafrugiperda insect cells by recombinant baculoviruses. In extracts from Jurkat T cells and U937 monocyte/macrophages Nef also associated with a 57 kDa cellular protein that was itself phosphorylated in vitro. Phosphorylation of this Nef-associated protein was inhibited by heparin and is thus likely to be mediated by casein kinase II. The observation that PKC can phosphorylate Nef in vitro raises the possibility that PKC might play a role in regulating both Nef function and the physical interactions between Nef and cellular components.
Introduction
The nef gene is conserved throughout the primate lentiviruses and encodes a protein product of between 205 [human immunodeficiency virus type 1 (HIV-1)] and 265 [simian immunodeficiency virus (SIV) amino acids that is co-translationally modified by the addition of an N-terminal myristic acid residue (Allan et al., 1985) . Data from the SIV system have demonstrated that nef plays an important role in the infectious process in vivo: SIV mutants with deletions in the nef gene failed to generate a pathogenic infection and virus loads were 1000-fold lower than with wild-type virus (Kestler et al., 1991) . The mechanism underpinning this role for nef in vivo is not clear but clues have emerged from a number of in vitro studies over the last few years. Firstly, Nef expression has been shown to result in the species-and cell type-independent down-modulation of the cell surface glycoprotein CD4 (Guy et al., 1987; Garcia & Miller, 1991; Garcia et al., 1993; Aiken et al., 1994; Anderson et al., 1994) . This down-modulation requires the cytoplasmic domain of CD4, in particular a dileucine motif known to be required for endocytosis of a number of cell-surface receptors (Aiken et al., 1994) . However, * Author for correspondence. Fax +44 41 330 5602. e-mail GVPA05 @ UDCF.GLA.AC.UK down-modulation is independent of serine phosphorylation within the cytoplasmic domain and thus occurs via a novel mechanism (Garcia et al., 1993) . Secondly, Nef expression results in an enhancement in the infectivity of virions in a CD4-independent fashion and has been shown to be important for the replication of HIV-1 in primary, quiescent lymphocytes (Miller et al., 1994; Spina et al., 1994) . Lastly, it has been shown that Nef can modulate signal transduction through the T cell receptor, in particular the activation of transcription factors NF-KB and AP-1 (Luria et al., 1991 ; Niederman et al., 1992 Niederman et al., , 1993 Bandres &Ratner, 1994) . Any or all of these aspects of Nef function may be expected to contribute to its importance for efficient viral replication in vivo.
The biochemical details underlying Nef function remain to be elucidated. It was originally suggested that Nef had limited sequence homology to the nucleotidebinding sites of protein kinases (Samuel et al., 1987) and G proteins such as Ras (Guy et al., 1987) and further to this, that purified bacterially expressed Nef could bind and hydrolyse GTP and also autophosphorylate (Guy et al., 1987) . We and others have subsequently shown that the observed nucleotide-binding activity of Nef was most likely due to the presence of bacterial GTP-binding proteins in the partially purified Nef preparations (Harris et al., 1992a; Backer et al., 1991; Nebreda et al., 1991) although a low level o f N e f a u t o p h o s p h o r y l a t i o n activity was observed in one o f these studies ( N e b r e d a et al., 1991) . Early studies suggested that N e f from HIV-1 strain Bru could be p h o s p h o r y l a t e d on a threonine residue at position 15 by protein kinase C ( P K C ) b o t h in vivo, following infection o f BHK-21 cells with a r e c o m b i n a n t vaccinia virus expressing Nef, and in vitro by incubation o f partially purified bacterially expressed N e f with P K C ( G u y et al., 1987) . M o r e recent studies failed to observe any p h o s p h o r y l a t i o n o f N e f translated in vitro by reticulocyte lysates (Poulin & Levy, 1992) , or expressed in T cells as a C D 8 -N e f fusion protein (Sawai et al., 1994) , although in b o t h these reports N e f a p p e a r e d to coi m m u n o p r e c i p i t a t e with a cellular protein kinase activity. In reticulocyte lysates the Nef-associated kinase activity p h o s p h o r y l a t e d a 46 k D a protein, in T cells two proteins o f 62 k D a and 72 k D a were p h o s p h o r y l a t e d . The question o f whether p h o s p h o r y l a t i o n plays a role in the function o f N e f in HIV-1-infected cells therefore remains open. As a preliminary step in attempting to answer this question we decided to investigate whether purified N e f protein could act as a kinase substrate in vitro. W e had previously expressed b o t h p r i m a r y clinical and labo r a t o r y isolates o f HIV-1 N e f as glutathione S-transferase (GST) fusion proteins in Escherichia coli and d e m o n s t r a t e d that the purified G S T -N e f fusion proteins failed to bind nucleotides or to a u t o p h o s p h o r y l a t e (Harris et al., 1992a) . Here we provide evidence that these fusion proteins however, d o act as kinase substrates in vitro and further show that one o f the kinases acting on N e f is P K C . However, c o n t r a r y to previous reports ( G u y et al., 1987; Laurent et al., 1990) , p h o s p h o r y l a t i o n o f N e f by P K C in vitro occurred p r e d o m i n a n t l y on serine residues and did not involve Thr-15. W e also report that N e f is p h o s p h o r y l a t e d when expressed in insect cells by r e c o m b i n a n t baculoviruses.
M e t h o d s
Construction of plasmids and purification of GST fusion proteins. The construction of pGEX-Nef expression vectors and the purification of GST, GST-BH10 and GST-PCR2 fusion proteins have all been described previously (Smith & Johnson, 1988; Harris et al., 1992a) . The construction of baculovirus vectors expressing Nef-GST and Nef-6H has also been described previously (Harris & Coates, 1993) .
Preparation of cellular extracts. Monolayers of HeLa and U373-MG cells were trypsinized and washed twice in ice-cold PBS. Suspension cells Jurkat and U937 were collected by centrifugation and washed as above. The cells were then lysed by sonication (3 x 10 s) on ice at a concentration of l0 s cetls/ml in lysis buffer (20 mM-HEPES/NaOH pH 7.5, 1 mM-EGTA, 10 mM-fl-glycerophosphate, 10 pM-sodium orthovanadate, 10 pM-microcystin, 50 mM-sodium fluoride, 0.4 mM-PMSF, 1 mM-DTT with the addition of benzamidine, leupeptin and pepstatin A to a final concentration of 5 pg/ml). Cell lysates were clarified by centrifugation (14000 r.p.m./30 min/4 °C), glycerol was added to 50 % (v/v) and the lysates were stored at -20 °C.
In vitro phosphorylation assay. GST or GST-Nef fusion proteins were bound to glutathione-agarose (GA) beads at a concentration of 2 mg/ml of packed beads. Twenty pg of bound protein was used per reaction. The beads were washed once in 20 rnM-HEPES/NaOH pH 7'5 before the addition of 25 pl of reaction mixture (20 mM-HEPES/NaOH pH 7"5, 1 mM-EGTA, 10 mM-MgCI2) plus 50 pM-ATP or GTP including 30 ~tCi D,-32P]ATP (ICN; 7000 Ci/mmol) or 30 ~tCi [y-3~P]GTP (Amersham; > 5000 Ci/mmol), respectively. The reaction was then started by the addition of 25 I11 of pre-cleared cell extract and incubated at 37 °C for 15 min. Unless otherwise indicated, all reactions were performed using Jurkat extracts. In the assay using purified PKC, 1 pl/0-09 U of enzyme (rat brain; Calbiochem) was added to the appropriate tubes with a further 25 pl of lysis buffer and incubated as above. Inhibitors were added as described in the figure legends. The beads were then washed five times with 0-5 ml 20 mM-HEPES/NaOH pH 7-5/1% Triton X-100 and boiled in reducing sample buffer before resolution by electrophoresis on a 12% SDS-PAGE gel. The proteins were transferred on to PVDF membrane (Immobilon-P; Millipore) by a standard electrotransfer method and either stained with Coomassie Brilliant Blue R250 or immunoblotted with monoclonal antibodies against Nef or GST as previously described (Harris & Coates, 1993) , before autoradiography to visualize labelled phosphorylated products.
Thrornbin cleavage of GST-Nef fusion proteins. In vitro phosphorylation was carried out as above. After the last wash, 30 pl of thrombin cleavage buffer (150 mM-NaC1, 2-5 mM-CaC12, 10 mM-Tris-HCI pH 8-0) was added to the beads together with 0"5 U of thrombin (Sigma). Reactions were incubated for a further 30 min at 37 °C and processed as described above. 
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Phosphoamino acid analysis. In vitro phosphorylation was carried out
as above with the exception that the amount of [~,-32P]ATP was increased to 50 laCi/reaction. Multiple reactions were resolved by SDS-PAGE, transferred on to PVDF membrane and stained with Coomassie Brilliant Blue R 2 5 0 before autoradiography. Phosphorylated GST-Nef bands were cut from the membrane and the proteins hydrolysed by incubation at 110 °C in 5-7M-HCI for 1 h. Phosphoserine, phosphothreonine, and phosphotyrosine standards (Sigma; 0'5 lag of each) were added to the hydrolysate prior to separation by two-dimensional thin layer electrophoresis on cellulose plates (Kodak). Unlabelled standards were located by spraying the dried plate with 0.2% ninhydrin (Sigma) and the radioactive phosphorylated amino acids were visualized by autoradiography.
In vivo phosphorylation of Nef Spodoptera frugiperda (Sf9) insect cells were infected at 5 p.f.u./cell recombinant baculoviruses expressing Nef-GST (AcNef-GST), Nef-6H (AcNef6H) or fl-galactosidase (AcRPlacZ) as negative controi. At 24 h post-infection (p.i.) cells were incubated with 100 I.tCi/ml [aZp]orthophosphate (Amersham; PBS 11), and at 40 h p.i. were harvested by lysis in 10 mM-PIPES/NaOH pH 7'2, 120 mM-KC1, 30 mM-NaCI, 5 mM-MgC12, 1% Triton X-100, 10% glycerol containing 10 mM-EDTA, 0-2 mM-PMSF, 2 lag/ml aprotinin, 1 lag/ml leupeptin and 10 tam sodium orthovanadate at a concentration of 2 x 106 cells/ml. Lysates were incubated at 4 °C for 30 min, clarified by centrifugation (12000 g for 5 min) and bound to either GA beads or Ni2+-NTA agarose. After separation of bound proteins by SDS-PAGE and transfer on to PVDF membrane, a2p-labelled proteins were detected by autoradiography. The positions of Nef-GST and Nef-6H were confirmed by immunoblotting with a sheep anti-Nef polyclonal serum.
Results
Cellular protein kinases phosphorylate HIV-1 N e f on serine residues in vitro
The nef gene of HIV-1 strain BH10, in which the of Jurkat cell extract (Fig. 1, lane 1) it was important to confirm that when G S T -N e f was used as substrate only Nef amino acid sequences were phosphorylated. To accomplish this we exploited the thrombin cleavage site that links GST and Nef in the p G E X construct. In vitro phosphorylated G S T -N e f was cleaved with thrombin and aliquots of cleavage products were analysed by SDS-PAGE followed by Coomassie Blue staining, immunoblotting with anti-Nef and anti-GST monoclonal antibodies to identify the Nef and GST moieties, and autoradiography to identify the phosphorylated product (Fig. 2) . As expected this analysis demonstrated that only the Nef portion of the fusion protein was phosphorylated. Phosphorylation of G S T -N e f was shown to be alkali labile and acid resistant (data not shown) suggesting that both the 5 5 k D a and 5 7 k D a bands were serine/ threonine rather than tyrosine phosphorylated. Further, to identify whether G S T -N e f was phosphorylated in vitro on either serine or threonine residues, phosphoamino acid analysis was carried out: G S T -N e f was phosphorylated in vitro and the reaction products separated by SDS-PAGE. The phosphorylated 55 kDa band was excised and subjected to acid hydrolysis followed by two-dimensional electrophoresis (Fig. 3) . This analysis revealed that the predominant phospho- amino acid was phosphoserine, although a very low level of phosphothreonine was also observed.
N e f is phosphorylated in vitro by P K C
Having established that Nef could function as a kinase substrate in vitro we wished to identify the kinase(s) responsible. A possible candidate was PKC, since it had been previously shown that PKC could phosphorylate Nef both in vivo and in vitro (Guy et al., 1987) . As PKC can only utilize ATP as phosphate donor, we examined whether the phosphorylation reaction showed any specificity for donor phosphate. In vitro phosphorylation reactions were carried with Jurkat extract in the presence of [y-3~P]ATP or [y-mP]GTP (Fig. 4) we also included a primary clinical isolate of Nef (PCR2) (Harris et al., 1992a) to verify that phosphorylation of Nef was not allele restricted. PCR2 and BH10 were phosphorylated with equal efficiency although only the 55 kDa band was observed in the presence of PCR2. Fig.  4 shows that both nucleotides were utilized with equal efficiency, implying that PKC was not involved. However, it was conceivable that PKC phosphorylation of Nef in the presence of [7-32p] GTP could have been permitted by ADP transphosphorylation by enzymes present in cell extracts. In vitro phosphorylation reactions were therefore carried out in the presence of a number of different protein kinase inhibitors (Fig. 5) . Phosphorylation of the 55 kDa G S T -N e f band was unaffected by heparin (an inhibitor of casein kinase II, lane 3), or a peptide inhibitor of cAMP-dependent kinases (lane 4). However phosphorylation was strongly inhibited by a pseudosubstrate peptide inhibitor of PKC (lane 5). We therefore tested whether purified PKC could phosphorylate Nef (Fig. 6) . Commercially available PKC (purified from rat brain) was able to efficiently phosphorylate Nef (lane 4). Phosphorylation of Nef by both purified PKC and Jurkat extract was inhibited by two specific PKC inhibitors with distinct modes of action: the pseudosubstrate peptide and bisindolylmaleimide (BIM), a competitive inhibitor of the ATP-binding site. As expected, purified PKC showed an absolute requirement for ATP as phosphate donor (data not shown). In contrast, phosphorylation of the 57 kDa band was inhibited by heparin but was not significantly affected by inhibitors of PKC or cAMP-dependent kinases (Fig. 5) , suggesting that this phosphorylation product was the result of casein kinase II activity. This suggestion was confirmed by the absence of the 57 kDa band from G S T -N e f preparations phosphorylated by purified PKC (Fig. 6) . PKC isoenzymes can be grouped into two categories based on their requirements for Ca 2÷ for activation (Osada et al., 1990) : isotypes ~, t , t 2 and 7 require Ca 2+, whereas 6, ~ and ~ are Ca2+-independent due to the lack of the C2 calcium-binding domain. The presence of 1 mM-EGTA in the cell extracts suggested that this latter group of Ca2+-independent PKC isotypes were responsible for Nef phosphorylation. This notion was backed up by the observation that addition of 2 mMCa 2÷ to the reactions containing cell extracts did not enhance phosphorylation (Fig. 5, lane 6 orthophosphate. Affinity purified Nef-GST or Nef~H were processed by SDS-PAGE and transferred to PVDF membrane followed by autoradiography. Parallel samples were analysed by immunoblotting with a polyclonal sheep anti-Nef serum followed by donkey anti-sheep horseradish peroxidase conjugate (Sigma), and developed using the enhanced chemiluminescence system (ECL; Amersham). Lysates from cells infected with AcRPlacZ (expressing fl-galactosidase) were processed identically and used as negative controls.
In vivo phosphorylation of N e f
We were unable to detect in vivo phosphorylation of N e f when expressed in mammalian cells, possibly because only low levels of N e f expression can be attained without cytotoxicity. However, we had previously demonstrated that the baculovirus expression system could support high levels of Nef expression (Harris & Coates, 1993; Harris & Nell, 1994) . This system was therefore exploited to investigate the possibility that N e f might be phosphorylated in vivo. Sf9 cells infected with recombinant baculoviruses expressing Nef with either GST (Nef~3ST) or six histidines (Nef~SH) at the C terminus were labelled with [s2p]orthophosphate. The resulting fusion proteins (Nef~GST or Nef-6H) were purified from lysates by affinity chromatography on G A beads or Ni~+-NTA agarose, respectively, and analysed by S D S -P A G E and autoradiography (Fig. 7) . This result clearly demonstrates that both N e f -G S T and N e f -6 H were phosphorylated when expressed in Sf9 cells. Furthermore the phosphorylated bands were alkali sensitive, indicating that phosphorylation was occurring on serine or threonine residues (data not shown).
Discussion
In this report we demonstrate that the HIV-1 Nefprotein is able to function as a kinase substrate in vitro. P K C was preliminarily identified as one of the kinases capable of phosphorylating Nef by virtue of the fact that phosphorylation of Nef by cell extracts was inhibited by specific P K C inhibitors, and furthermore, purified P K C could phosphorylate Nef in the absence of cell extract (Fig. 6) . In this regard our data are in agreement with an earlier study (Guy et al., 1987) In contrast an alanine was present at position 15 in the Nef protein used in this study (BH10) and phosphoamino acid analysis revealed that the predominant phosphorylated residue was serine (Fig. 3) . This discrepancy may be explained by differences in the purification protocols. Guy et al. (1987) obtained 75 % pure Nef protein by SDS solubilization of an insoluble fraction. In contrast, the protein used in this study was purified to homogeneity by affinity chromatography on glutathione agarose and was not exposed to denaturing agents. Our data therefore imply that in native Nef, Thr-15 is not the sole target for PKC action. Further experiments with a number of primary clinical isolates of Nef that contained threonine residues at position 15 (Harris et al., 1992a) indicated that the presence of this residue did not enhance the levels of phosphorylation (data not shown). Although PKC cannot utilize GTP as phosphate donor, phosphorylation of Nefin the presence of [7-32p]GTP does not rule out PKC as the kinase since enzymes present in cell extracts may transphosphorylate ADP. Amino acid sequencing of tryptic peptides derived from in vitro phosphorylated GST-Nef has thus far failed to identify the phosphorylated serine(s). HPLC and two-dimensional separations of tryptic digests revealed the existence of three phosphorylated species (data not shown), suggesting that up to three phosphorylation sites may exist. Mutation of the serine at position 6 did not affect the levels of phosphorylation (data not shown), however, there are a number of serine residues in Nef that lie in environments rich in basic amino acids that might be candidate PKC phosphorylation sites, these include serines at 103 and 169.
The identity of the 57 kDa phosphorylated band is unknown. It is likely to be a cellular protein that interacts with Nef as it was not detected by immunoblotting with anti-Nef sera (data not shown). We had previously identified proteins of 55/57 kDa in extracts of metabolically labelled Jurkat cells that interacted with a baculovirus-expressed myristylated Nef~GST fusion protein in vitro (Harris & Coates, 1993) . These proteins were also observed to a lesser extent in association with non-myristylated Nef~GST (Harris & Coates, 1993 ) and E. coli-expressed GST-Nef (Harris et al., 1992b) . It is tempting to speculate that the phosphorylated 57 kDa band observed in this study corresponds to the metabolically labelled 57 kDa protein identified in the previous study. In the light of our recent observation of a direct interaction between Nef-GST and CD4 in vivo (Harris & Neil, 1994) it is interesting to note that the extracts that gave rise to the 57 kDa band were derived from CD4-positive cells. However CD4 was not detected in GST-Nef precipitates by immunoblotting (data not shown), thus the 57 kDa band is unlikely to correspond to CD4. Furthermore, CD4 is known to be serine phosphorylated by PKC (Shin et al., 1994) , whereas phosphorylation of the 57 kDa band described here was inhibited by heparin, implicating casein kinase II. Interestingly, a recent report (Sawai et al., 1994) described an as yet unidentified 62 kDa protein (62K) from Jurkat T cells that co-immunoprecipitated with a CD8-Nef fusion protein and was serine phosphorylated when immunoprecipitates were subjected to in vitro kinase assays. The position of the 62K protein on gels is very similar to that observed for the 57K protein, differences in gel systems may account for the discrepancy in observed molecular weights. Further indirect evidence that these proteins may be related lies in the fact that their phosphorylation was unaffected by inhibitors of either PKC or PKA.
As yet we have not been able to demonstrate serine phosphorylation of Nef in vivo in mammalian cells constitutively expressing Nef. This may be explained by the apparent cytotoxicity of Nef and the consequence that only low levels of Nef expression can be tolerated by mammalian cells. In addition, in vivo phosphorylation of Nef may be a transient event, only occurring under specific conditions of cell activation. Experiments are presently underway to develop inducible mammalian expression systems that may help to clarify this discrepancy. However, we have observed serine/threonine phosphorylation of Nef expressed in Sf9 insect cells by recombinant baculovirus vectors with either a C-terminal GST or six histidine tag (Fig. 7) , demonstrating that Nef can be phosphorylated in vivo, albeit in a heterologous system.
The role of phosphorylation in the function of Nef in vivo remains to be elucidated. Phosphorylation plays a critical role in modulating the activity of a large number of cellular and viral proteins. In addition, phosphorylation is involved in protein-protein interactions and can influence the subcellular localization of proteins. A pertinent example of these two roles of phosphorylation is the myristylated alanine-rich C kinase substrate protein (MARCKS), a protein involved in regulating actin/ membrane interactions (Aderem, 1992) . PKC phosphorylation of MARCKS results in its release from the plasma membrane and inhibits its binding to calmodulin and actin. The similarities between Nef and MARCKS (they are both PKC-phosphorylated, myristylated proteins located on the plasma membrane) lead to the intriguing possibility that PKC phosphorylation might regulate both the localization of Nef on the plasma membrane and the interactions between Nef and cellular proteins. Amongst its many functions PKC plays a pivotal role in the process of T cell activation (Crabtree, 1989 
